AIM Stock Price and Chart — AMEX:AIM — TradingView

Overview

Financials News Ideas Technicals Forecast

AIM chart

Key stats

About AIM ImmunoTech Inc.

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.

Financials

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

‪0.00‬

Ideas

See all ideas

News

Technicals

Summarizing what the indicators are suggesting.

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Stocks, Futures

4.4Very Good

Interactive Brokers

4.4Very Good

See all brokers

Frequently Asked Questions

The current price of AIM is 0.4848 USD — it has decreased by 13.74% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange AIM ImmunoTech Inc. stocks are traded under the ticker AIM.

AIM ImmunoTech Inc. is going to release the next earnings report on May 16, 2024. Keep track of upcoming events with our Earnings Calendar.

One year price forecast for AIM ImmunoTech Inc. has a max estimate of 2.0000 USD and a min estimate of 2.0000 USD.

AIM earnings for the last quarter are −0.16 USD whereas the estimation was −0.11 USD which accounts for −41.18% surprise. Estimated earnings for the next quarter are −0.12 USD. See more details about AIM ImmunoTech Inc. earnings.

AIM ImmunoTech Inc. revenue for the last quarter amounts to ‪46.00 K‬ USD despite the estimated figure of ‪24.00 K‬ USD. In the next quarter revenue is expected to reach ‪36.50 K‬ USD.

Yes, you can track AIM ImmunoTech Inc. financials in yearly and quarterly reports right on TradingView.

Like other stocks, AIM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AIM ImmunoTech Inc. stock right from TradingView charts — choose your broker and connect to your account.

AIM reached its all-time high on Mar 2, 2000 with the price of 10 036.0128 USD, and its all-time low was 0.2910 USD and was reached on Dec 30, 2022.
See other stocks reaching their highest and lowest prices.

As of Apr 16, 2024, the company has 26.00 employees. See our rating of the largest employees — is AIM ImmunoTech Inc. on this list?

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AIM ImmunoTech Inc. EBITDA is ‪−31.62 M‬ USD, and current EBITDA margin is ‪−15.68 K‬%. See more stats in AIM ImmunoTech Inc. financial statements.